Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn's Disease Who Lost Response to Maintenance Therapy

Por Motoya, Satoshi, Watanabe, Mamoru, Wallace, Kori, Lazar, Andreas, Nishimura, Yasuko, Ozawa, Morio, Thakkar, Roopal, Robinson, Anne M., Singh, Ravi Shankar Prasad, Mostafa, Nael M., Suzuki, Yasuo, Hibi, Toshifumi
Publicado no Inflamm Intest Dis (2018)